Navigation Links
Free Article Now Available: 'Rights Expanding for Plaintiffs with In Utero Injuries'
Date:11/11/2008

r thinking over the years to reflect new medical knowledge and technology. The article is interesting, touching on issues of public policy, informed consent and a physician's professional duties.

To view the entire article, click here

"At Clifford Law Offices, we offer free articles to educate people about subjects such as a plaintiff's rights and medical injuries," says Robert A. Clifford, Founder.

About Clifford Law Offices:
Clifford Law Offices is ranked one of the top Chicago law firms. The staff includes an experienced , medical injury attorney, accident lawyer, injury lawyer, Chicago lawyers, Chicago attorneys, birth injury lawyers, chicago injury attorney, hospital injury lawyer, Chicago medical malpractice lawyers, and more.

Toll Free: (800) 899-0410
Phone: (312) 899-9090
Fax: (312) 251-1160
Clifford Law Offices

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1570114.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
2. Stages Of Grief Refuted As Inaccurate and Dangerous By Grief Recovery Institute Founders In Skeptic Magazine Article
3. Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
4. Particle Sciences Develops Methods for Increasing Quality of Sintered Metal Products and for Coating Surfaces with Metal Oxide Films
5. Particle Sciences Develops Zero-Order-Release Combination Device Technology
6. Free articles get read but dont generate more citations
7. New disease-fighting nanoparticles look like miniature pastries
8. Nanoparticles + light = dead tumor cells
9. Using magenetic nanoparticles to combat cancer
10. Elseviers "ScienceDirect" Articles Surpass Nine-Million Mark
11. Nanoparticle Stops Cancer From Spreading
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 1National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 2National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers 61647 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 1Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 2Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 3Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 4Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 5Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 6Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 7Reportlinker Adds Biotechnology Reagents A Global Market Perspective 14905 8Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 1Improving Quality Cost Effectiveness and Time Savings in Preclinical Inhalable Formulation Development 6386 2